Skip to content

Washington Trust Bancorp WASH Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Bank of America logo
Bank of AmericaBAC
12.8B0.0%
CTB
Community Trust BancorpCTBI
Citizens Financial Group logo
Citizens Financial GroupCFG
West Bancorporation logo
West BancorporationWTBA
Eagle Bancorp logo
Eagle BancorpEGBN
Customers Bancorp logo
Customers BancorpCUBI

Other financials

Income statement

See full
Revenue$57.8M-2.1%
Net income$12.6M+3.5%
EPS (diluted)$0.66+4.8%

Balance sheet

See full
Cash & equivalents$100.2M-16.7%
Total debt$38.7M0.0%
Total equity$546.8M+4.8%
Total assets$6.5B-1.9%

Cash flow

See full
Operating cash flow$16.1M+90.9%
CapEx$1.3M+1,384%
Free cash flow$14.8M+77.3%

Valuation

See full
Market cap$691.7M+33.7%
Enterprise value$630.24M+44.7%
P/E13.1×
P/S

Profitability

See full
Net margin23.1%
FCF margin37.2%

Returns & leverage

See full
Return on equity9.9%+7.3pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Washington Trust Bancorp in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Washington Trust Bancorp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Washington Trust Bancorp's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Washington Trust Bancorp's common stock, shares authorized (in shares)?
Washington Trust Bancorp (WASH) reported common stock, shares authorized (in shares) of $60M in Q1 2026.
How has Washington Trust Bancorp's common stock, shares authorized (in shares) changed year-over-year?
Washington Trust Bancorp's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $60M to $60M.
What is the long-term trend for Washington Trust Bancorp's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Washington Trust Bancorp's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $60M to $60M.